Abel De La Rosa, PhD
Abel De La Rosa, Ph.D. has held postions as Senior Vice President, Business Development & Scientific Affairs with Pharmasset and Vice President of Product Development and Director of Strategic Marketing and Latin American Business at Visible Genetics, Inc.. He was responsible for the development, transfer and improvement of products, including TRUGENE HIV-1 v1.0 Genotyping Test ® and other sequencing-based assays for HCV and HBV. Dr. De La Rosa also previously held positions at Innogenetics, Inc., Boston Biomedica, Inc., and Digene Corp. Prior to joining Digene, he completed two NIH Post-Doctoral Fellowships at the National Cancer Institute, an IRTA Fellowship in the Laboratory of Pathology and a Fogarty Fellowship in the Laboratory of Biochemistry. He is an inventor and author on several U.S. patents and publications relating to molecular diagnostic methods and techniques for infectious diseases and cancer. Dr. De La Rosa received a B.A. in Microbiology from the University of California, San Diego, and an M.S. and Ph.D. in Microbiology from Miami University.